"Beaumont Hospital, Grosse Pointe opened in 1945 by the Sisters of Bon Secours, it was acquired by Beaumont Health System in October 2007. Beaumont, Grosse Pointe offers medical, surgical, emergency, obstetric and critical care services."

During the past decade, William Beaumont Hospital-Grosse Pointe conducted 34 clinical trials. In the 10-year time frame, 34 clinical trials started and 20 clinical trials were completed, i.e. on average, 58.8% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 20 clinical trials were completed. i.e. 2000% of trials that started reached the finish line.

Out of the total clinical trials conducted in "William Beaumont Hospital-Grosse Pointe" #1 sponsor was "National Cancer Institute (NCI)" with 17 trials, followed by "SWOG Cancer Research Network" with 11 trials sponsored, "Alliance for Clinical Trials in Oncology" with 7 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 4 trials sponsored and "NRG Oncology" with 4 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "William Beaumont Hospital-Grosse Pointe" #1 collaborator was "National Cancer Institute (NCI)" with 23 trials as a collaborator, "Canadian Cancer Trials Group" with 6 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Bayer" with 1 trials as a collaborator and "Blue Cross Blue Shield of Michigan Foundation" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "William Beaumont Hospital-Grosse Pointe" are "Recurrent Squamous Cell Lung Carcinoma" (7 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (6 trials), "Stage IIIA Breast Cancer" (4 trials), "HER2/Neu Negative" (3 trials) and "Recurrent Breast Carcinoma" (3 trials). Many other conditions were trialed in "William Beaumont Hospital-Grosse Pointe" in a lesser frequency.

Most popular intervention types in "William Beaumont Hospital-Grosse Pointe" are "Drug" (34 trials), "Other" (33 trials), "Biological" (13 trials), "Procedure" (9 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (21 trials), "Quality-of-Life Assessment" (11 trials), "Computed Tomography" (5 trials), "Nivolumab" (5 trials) and "Placebo Administration" (5 trials). Other intervention names were less common.

The vast majority of trials in "William Beaumont Hospital-Grosse Pointe" are 37 trials for "All" genders and 5 trials for "Female" genders.

Currently, there are NaN active trials in "William Beaumont Hospital-Grosse Pointe". undefined are not yet recruiting, 3 are recruiting, 26 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in William Beaumont Hospital-Grosse Pointe, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in William Beaumont Hospital-Grosse Pointe, 0 "Phase 1" clinical trials were conducted, 17 "Phase 2" clinical trials and 26 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".